Ambu stock gains as JPMorgan turns cautious
Published on 09/09/2026 at 19:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ambu stock (ISIN DK0060946788) closed at DKK 91.20 on Nasdaq Copenhagen on September 8, 2026, up 0.9 percent. The move came after Investing.com reported on September 9, 2026, that JPMorgan put Ambu on Negative Catalyst Watch ahead of fourth-quarter results on November 5.
Price held a tight range
On September 8, 2026, Ambu traded between DKK 90.70 and DKK 91.65, while volume reached 1.2 million shares. The session beat the OMX Copenhagen 20 by 1.3 percentage points, after the index fell 0.4 percent.
That leaves the stock close to the upper half of its daily range. For investors, the next checkpoint is the November 5 reporting date that JPMorgan flagged in its note.
JPMorgan sees margin risk
According to Investing.com, JPMorgan kept Ambu at neutral and cited concern around fiscal 2027 margin guidance. The broker said consensus expects about 230 basis points of margin expansion, but foreign exchange, rolling off tariff refunds and continued growth investment could make that look optimistic.
The same report said the European medtech sector was flat in the third quarter and down 4 percent in the first week of September. That wider backdrop helps explain why Ambu was singled out as a risk name even without a company update on the day.
Trading level to watch
Ambu stock ended September 8, 2026, at DKK 91.20 on Nasdaq Copenhagen, after a session low of DKK 90.70 and a high of DKK 91.65. The next full-year check for the market is the November 5 results date cited by JPMorgan.
Ambu at a glance
- Company: Ambu A/S
- ISIN: DK0060946788
- Ticker: AMBU
- Trading venue: Nasdaq Copenhagen
- Price (as of September 8, 2026, 17:20): DKK 91.20
- Market capitalization: DKK 15.65 billion (as of September 8, 2026)
- Sector / Industry: Health Care / Health Care Equipment
- Index membership: OMX Copenhagen 20
- Next earnings date: November 5, 2026
